AI & ALS Neurodegeneration Drug Development
AI & ALS Neurodegeneration Drug Development
Articles on experimental drug development targeting ALS and TDP-43 neurodegeneration, including blood-brain barrier penetration, precision small-molecule therapeutics, and neuroprotective mechanisms for motor neuron diseases.
ai als neurodegeneration drug development45 minutes ago3 min
The Tiny Drug That Slips Past the Brain's Fortress to Stop ALS in Its Tracks
University of Arizona researchers developed XL20, a brain-penetrant small molecule that targets a conserved region of TDP-43, halting toxic protein aggregation and extending survival in ALS mouse models while preserving healthy cellular function.